Aug 12, · The emergence of new biological drugs for the treatment of psoriasis, such as interleukin (IL)‐17 and IL‐23 inhibitors, has reignited the subject of tuberculosis reactivation as it is possible that IL‐17 and 23 blockade do not carry the same risk of TB reactivation as TNF‐α inhibitorsApr 29, · IL23 has emerged as an important inflammatory cytokine in the pathogenesis of psoriasis We continue our series, Therapeutic Cheat Sheet, with a closer look at IL23 inhibitors Click image to enlarge Overall, IL23 inhibitors have demonstrated superior efficacy and safety in the treatment of psoriasisPSOLAR) have shown the IL‐12/23p40 inhibitor ustekinumab to be well tolerated in patients with psoriasis 2226 However, another
Why Did Il 23p19 Inhibition Fail In As A Tale Of Tissues Trials Or Translation Annals Of The Rheumatic Diseases